Latest Center for Devices and Radiological Health Stories
CDRH has recently overhauled its Office of Compliance — what exactly has changed and what hasn’t? In this exclusive question-and-answer webinar rebroadcast, FDA veteran Steve Niedelman, lead
Maria Isabel Tejero del Rio, MD, PhD, Lead Consumer Safety Officer, Division of Manufacturing and Quality, Office of Compliance, CDRH, FDA is confirmed as the opening Keynote speaker at FDAnews’
Many of the problems uncovered during inspections are common and recurring problems within the drug and device industry. In this webinar, Dr.
According to a recent study, the approval of drugs by the Food and Drug Administration (FDA) is based on widely varying clinical trials between 2005 and 2012.
CDRH has recently overhauled its Office of Compliance — what exactly has changed and what hasn’t? In this exclusive question-and-answer webinar, FDA veteran Steve Niedelman, lead quality
More than 30 regional and state organizations urge Congress to end sequestration of industry-paid user fees LA JOLLA, Calif.
d’Oliveira & Associates has released a new infographic about the Stryker Oasys recall.
This Summit will bring together regulators, drug and device makers and industry inspection experts.
Smartphone technology opens a new world for medical device innovation.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.